Swiss National Bank Sells 7,100 Shares of Axon Enterprise, Inc $AXON

Swiss National Bank decreased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 3.2% during the third quarter, HoldingsChannel.com reports. The fund owned 213,200 shares of the biotechnology company’s stock after selling 7,100 shares during the period. Swiss National Bank’s holdings in Axon Enterprise were worth $153,001,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Axon Enterprise by 4.2% in the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock worth $6,684,217,000 after purchasing an additional 376,904 shares during the last quarter. Geode Capital Management LLC grew its holdings in Axon Enterprise by 5.9% during the second quarter. Geode Capital Management LLC now owns 2,072,186 shares of the biotechnology company’s stock valued at $1,713,332,000 after purchasing an additional 115,349 shares during the last quarter. Jennison Associates LLC grew its holdings in Axon Enterprise by 53.8% during the third quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock valued at $677,412,000 after purchasing an additional 330,213 shares during the last quarter. Vestor Capital LLC raised its position in shares of Axon Enterprise by 438,636.3% in the second quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock valued at $690,170,000 after purchasing an additional 833,409 shares during the period. Finally, Norges Bank acquired a new stake in shares of Axon Enterprise in the second quarter worth $637,806,000. 79.08% of the stock is owned by institutional investors.

Insider Transactions at Axon Enterprise

In related news, CFO Brittany Bagley sold 2,000 shares of the company’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $580.00, for a total value of $1,160,000.00. Following the completion of the transaction, the chief financial officer directly owned 103,501 shares in the company, valued at approximately $60,030,580. This represents a 1.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total value of $860,175.00. Following the completion of the transaction, the chief accounting officer directly owned 12,240 shares of the company’s stock, valued at approximately $7,019,028. This trade represents a 10.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 26,634 shares of company stock worth $14,963,095 over the last quarter. 5.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on AXON shares. Northcoast Research raised shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price objective for the company in a report on Tuesday, January 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Wall Street Zen raised shares of Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. Barclays decreased their price target on shares of Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Finally, Craig Hallum reaffirmed a “buy” rating and issued a $820.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $762.93.

Axon Enterprise Stock Down 2.6%

NASDAQ AXON opened at $559.06 on Tuesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. The firm has a 50-day simple moving average of $535.65 and a 200 day simple moving average of $615.42. Axon Enterprise, Inc has a twelve month low of $396.41 and a twelve month high of $885.91. The stock has a market cap of $44.95 billion, a PE ratio of 367.81, a PEG ratio of 12.25 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The business had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The firm’s revenue for the quarter was up 38.5% compared to the same quarter last year. During the same period last year, the business earned $2.08 earnings per share. On average, research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.